Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CroatiaBack to Croatia

Clinical trials in Cepin

4 clinical trials in Cepin, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Cepin at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Cepin

Open in trial search

Cardiovascular disorder+2

Recruiting
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Cardiac failure chronic+1

Recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Cardiac failure

Not recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Cepin

What the registry says about research in the country

01 Cepin
Cardiovascular Diseases
Clinical trial activity in Cepin is focused entirely on cardiovascular diseases, with studies exploring new ways to reduce heart-related events and improve long-term outcomes for people living with complex heart conditions. Chronic heart failure Heart failure with mildly reduced or preserved ejection fraction Heart failure with reduced ejection fraction Heart condition These trials are mainly testing whether newer treatments can better control inflammation, protect the heart, and lower the risk of hospitalization or cardiovascular death.
Heart Failure and Inflammation
Several studies are examining heart failure together with systemic inflammation, aiming to see whether targeted therapy can improve outcomes for patients with HFmrEF and HFpEF. HFmrEF HFpEF Systemic inflammation Cardiovascular death and heart failure events This research is designed to evaluate a potential new treatment approach for people whose heart failure is linked with inflammatory activity.
Heart Failure Treatment Options
Another important area of research is the management of heart failure in patients who cannot use standard mineralocorticoid receptor antagonists, with studies looking at both effectiveness and safety. HFrEF Finerenone Safety and tolerability Standard heart failure care These trials are intended to expand treatment options for people with limited access to current therapies.
Diabetes, Hypertension, and Cardiovascular Risk
Research in the city also includes patients with type 2 diabetes, hypertension, and established cardiovascular disease, reflecting the close link between metabolic and heart health. Type 2 diabetes High blood pressure Established cardiovascular disease Heart-related hospital visits These studies are focused on whether combining therapies can better prevent serious cardiovascular events in high-risk patients.
Iron Deficiency in Chronic Heart Failure
One trial is exploring whether treating iron deficiency in people with symptomatic chronic heart failure can improve survival and reduce worsening heart failure. Symptomatic chronic heart failure Iron deficiency Ferric derisomaltose Hospitalization prevention This line of research aims to clarify the role of iron replacement as part of comprehensive heart failure care.
Back to CroatiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.